Innventure has established a Strategic Review Committee to evaluate capital strategies and enhance shareholder value amid liquidity challenges. The company is focused on cost reductions, including a 57% payroll cut, and supports independent fundraising at its operating companies. It introduced an at-the-market equity program to manage capital needs without excessive dilution. Leadership changes and governance improvements aim to strengthen oversight as Innventure pursues strategic alternatives for its subsidiaries AeroFlexx and Refinity.
Innventure's strategic review committee announcement provides context for financial sector activity on Pluang. As of Nov 02, 2026 19:51 WIB, 84 of 142 Financials-sector US stocks rose while 26 fell. Notably, BBVA traded at USD 23.89 with a 1-day gain of 1.92% and a typical hold time of 84 days, contrasting with Galaxy Digital Inc. at USD 16.29, up 1.81% but held for only 9 days, and Regions Financial at USD 29.06, up 1.72% with a 12-day hold time.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
